Viridian Therapeutics Inc...

NASDAQ: VRDN · Real-Time Price · USD
18.53
0.09 (0.49%)
At close: Aug 15, 2025, 3:59 PM
18.50
-0.16%
After-hours: Aug 15, 2025, 07:26 PM EDT

Viridian Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-100.73M -86.91M -79.72M -76.69M -64.99M -48.54M -66.86M -47.66M -55.06M -68.15M -45.78M -28.91M -29.49M -25.69M -28.95M -14.04M -17.96M -18.46M
Depreciation & Amortization
113K 117K 123K -12.62M 142K 345K 150K 135K 132K 105K 96K 62K 57K 40K 32K 30K 25K 33K
Stock-Based Compensation
10.84M 10.22M 8.97M 8.72M 11.77M 12.69M 26.05M 13.61M 12.3M 15.22M 5.28M 4.94M 4.88M 4.66M 3.49M 3.98M 3.82M 3.17M
Other Working Capital
11.23M -15.62M 4.37M -9M 10.59M -5.44M 7.13M -3.98M -926K 384K 5.51M -5.13M -72K -400K 2.36M -4.55M 1.48M 771K
Other Non-Cash Items
-1.46M -2.22M -3.17M 19.05M -4.1M 8.14M 112K 1.38M 5.02M -2.88M -888K 313K 48K 321K 7.68M 1M -1.2M -5K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -3.07M -2.36M -2.91M n/a n/a n/a n/a n/a 248K 242K 316K 232K
Change in Working Capital
15.87M -13.86M 460K -6.17M 11.13M -4.96M 5.62M -4.08M -4.7M -6.26M 7.26M 2.92M 6.16M -369K 958K -3.09M 370K 3.49M
Operating Cash Flow
-75.37M -92.65M -73.33M -67.71M -46.06M -45.22M -38M -38.98M -45.21M -61.97M -34.04M -20.67M -18.09M -21.04M -16.54M -11.88M -14.63M -11.54M
Capital Expenditures
-42K -86K -114K -293K -104K n/a -48K -404K -331K -115K -231K -95K -292K -179K -84K -185K -54K -15K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 169.66M -48.45M -41.04M 13.18M 180.37M n/a n/a n/a 2K 2K 75K n/a
Purchase of Investments
-55.76M -71.24M -181.78M -228.42M -59.26M -225.61M -272.5M -50.05M -8.06M -77.28M -218.07M n/a n/a -5.19M -102.88M -18.17M -10.73M -56.65M
Sales Maturities Of Investments
131.51M 171.39M 118.98M 144.05M 121.34M 82.56M 102.83M 98.49M 49.1M 64.1M 37.7M 42.75M 14.26M 14.23M 22.76M 24.6M -497K 67.54M
Other Investing Acitivies
n/a n/a n/a n/a n/a -143.04M -169.66M 48.45M 41.04M -13.18M -180.37M 42.75M 14.26M 9.04M 2K 2K 75K 10.89M
Investing Cash Flow
75.72M 100.06M -62.91M -84.67M 61.98M -143.04M -169.71M 48.04M 40.71M -13.29M -180.6M 42.65M 13.96M 8.86M -80.21M 6.25M -11.21M 10.87M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a 15M n/a n/a 446K n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a 320K n/a n/a n/a 71K n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
763K 4.27M n/a 11.27M 108K -9.18M -2.32M 457K 3.07M 8.2M 482K 24.15M 4.56M 738K -834K 12.09M -218K n/a
Financial Cash Flow
764K 9.21M 35.52M 245.02M 108K 177.08M 198.94M 15.46M 3.07M 8.2M 26.01M 290.93M 4.56M 738K 170K 116.79M 7.05M 1.26M
Net Cash Flow
1.11M 16.62M -100.72M 92.65M 16.03M -11.19M -8.77M 24.52M -1.43M -67.06M -188.63M 312.92M 435K -11.44M -96.58M 111.17M -18.79M 592K
Free Cash Flow
-75.42M -92.74M -73.45M -68M -46.16M -45.22M -38.05M -39.39M -45.55M -62.09M -34.27M -20.76M -18.38M -21.22M -16.62M -12.06M -14.69M -11.55M